Amanote Research
Register
Sign In
Human Medicines European Public Assessment Report (EPAR): Briviact (In Italy: Nubriveo), Brivaracetam, Epilepsy, Date of Authorisation: 13/01/2016, Revision: 6, Status: Authorised
Case Medical Research
doi 10.31525/cmr-11ef042
Full Text
Open PDF
Abstract
Available in
full text
Date
May 6, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Human Medicines European Public Assessment Report (EPAR): Bronchitol, Mannitol, Cystic Fibrosis, Date of Authorisation: 13/04/2012, Revision: 13, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Pregabalin Pfizer, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 10/04/2014, Revision: 13, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Pregabalin Accord, Pregabalin, Anxiety Disorders,Epilepsy, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Levetiracetam Sun, Levetiracetam, Epilepsy, Date of Authorisation: 14/12/2011, Revision: 11, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Lenvima, Lenvatinib, Thyroid Neoplasms, Date of Authorisation: 28/05/2015, Revision: 6, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Xyrem, Sodium Oxybate, Cataplexy,Narcolepsy, Date of Authorisation: 13/10/2005, Revision: 29, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Silodosin Recordati, Silodosin, Prostatic Hyperplasia, Date of Authorisation: 07/01/2019, Status: Authorised
Case Medical Research
Human Medicines European Public Assessment Report (EPAR): Colobreathe, Colistimethate Sodium, Cystic Fibrosis, Date of Authorisation: 13/02/2012, Revision: 10, Status: Authorised
Case Medical Research
